CONTACT
+91 80 2808 2808
info@biocon.com

News - Posts

Biocon  /  News – Posts

Biocon Pharma Limited Receives Health Canada Approval for Micafungin for Injection, USP, 50 MG and 100 MG
  • Mon, 11-May-2026
  • Posted by: BIOCON
No Comments

Biocon Q4FY26 Total Income at Rs 4,569 Cr EBITDA at Rs 1,073 Cr; Net Profit (before exceptional items) at Rs 179 Cr FY26 Total Income at Rs 17,270 Cr; EBITDA at Rs 3,798 Cr; Net Profit (before exceptional items) at Rs 436 Cr
  • Thu, 07-May-2026
  • Posted by: BIOCON
No Comments

U.S. FDA Completes Pre-License Inspection at Biocon’s Biosimilars Site at Biocon Park, Bengaluru, India
  • Thu, 30-Apr-2026
  • Posted by: BIOCON
No Comments

Biocon Receives Health Canada Approval of Bosaya™ (Denosumab) and Vevzuo™ (Denosumab), Biosimilars to Prolia® and Xgeva®
  • Tue, 21-Apr-2026
  • Posted by: BIOCON
No Comments

Biocon Pharma Limited Receives U.S. FDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg
  • Wed, 08-Apr-2026
  • Posted by: BIOCON
No Comments

Biocon Announces U.S. Commercial Launch of Bosaya™ and Aukelso™, Denosumab Biosimilars
  • Tue, 07-Apr-2026
  • Posted by: BIOCON
No Comments

Biocon Foundation, in partnership with BeST Cluster and NCBS, onboards first BioWISE cohort of Postgraduate Women Students
  • Fri, 03-Apr-2026
  • Posted by: BIOCON
No Comments

Shreehas Tambe Appointed CEO & Managing Director of Biocon Limited, Effective April 1, 2026
  • Fri, 27-Mar-2026
  • Posted by: BIOCON
No Comments

Biocon Pharma Limited Receives U.S. FDA Approval for Liraglutide Injection gVictoza®
  • Thu, 12-Mar-2026
  • Posted by: BIOCON
No Comments

Biocon obtains approval for weight management drug, Liraglutide, in the United States
  • Wed, 25-Feb-2026
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2026, Biocon. All Rights Reserved
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>